Announcements Trials
Browse Landscape

Phase

Phase 1 8Phase 1/2 6Phase 2 5Phase NA 2Phase EARLY_PHASE1 1Phase 4 1Phase 3 1

Status

Terminated 2Completed 2Unknown 1Recruiting 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

CNS 6Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 14Brain Neoplasms 12Lung Neoplasms 8Neoplasm Metastasis 7Pancreatic Neoplasms 6Liver Neoplasms 6Glioblastoma 6Squamous Cell Carcinoma of Head and Neck 5Carcinoma, Hepatocellular 5Prostatic Neoplasms 4Melanoma 4Carcinoma, Renal Cell 4Neoplasms 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Ovarian Neoplasms 2Neurologic Manifestations 2Glioma 2Colorectal Neoplasms 2Wilms Tumor 1Urinary Bladder Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Unspecified Adult Solid Tumor 1Stomach Neoplasms 1Spinal Neoplasms 1Spinal Cord Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Sarcoma 1Salivary Gland Neoplasms 1

Interventions

Temozolomide 69Radiotherapy 30Bevacizumab 24Carboplatin 13pembrolizumab 12Radiation 11Carmustine 8Irinotecan 7temsirolimus 6Surgical Procedures, Operative 6Radiosurgery 6Erlotinib Hydrochloride 6atezolizumab 5Vorinostat 5Sirolimus 5Radiotherapy, Intensity-Modulated 5Nivolumab 5Lomustine 5Everolimus 5fludarabine 4Radiotherapy, Conformal 4Magnetic Resonance Spectroscopy 4Cyclophosphamide 4Aminolevulinic Acid 4tipifarnib 3Sorafenib 3Paclitaxel 3IL13-PE38 3Granulocyte-Macrophage Colony-Stimulating Factor 3Gemcitabine 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 1/2 × Glioblastoma × Radiosurgery × Clear all
NCT04977375 2025-09-03

Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma

Cedars-Sinai Medical Center

Phase 1/2 Recruiting
10 enrolled
CNS

Brain Neoplasms, Glioblastoma, Glioma, Spinal Cord Neoplasms, Central Nervous System Neoplasms

NCT02085304 2024-04-19

Tumor Resection and Gliadel® Wafers, Followed by Temodar® With Standard Radiation or GammaKnife® for New GBM

St. Joseph's Hospital and Medical Center, Phoenix

Phase 1/2 Terminated
8 enrolled
CNS

Glioblastoma

NCT02052648 2024-03-27

Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors

Lumos Pharma

Phase 1/2 Completed
160 enrolled 21 charts
CNSSarcoma

Brain Neoplasms, Glioblastoma, Glioma, Gliosarcoma

NCT05131711 2021-11-23

CSREIG

Beijing Tiantan Hospital

Phase 1/2 Unknown
60 enrolled
CNS

Glioblastoma

NCT01120639 2021-08-06

Tx-Treatment

Stanford University

Phase 1/2 Completed
30 enrolled 19 charts
CNS

Brain Neoplasms, Glioblastoma, Neurologic Manifestations

NCT00456612 2017-03-06

Radiosurgery for Glioblastoma Multiforme

Beth Israel Deaconess Medical Center

Phase 1/2 Terminated
4 enrolled 3 charts
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡